Search Results

There are 3065 results for: content related to: Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents

  1. NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis Risk: Is There a Difference between Gadolinium-Based Contrast Agents?

    Seminars in Dialysis

    Volume 21, Issue 2, March/April 2008, Pages: 129–134, Jeffrey G. Penfield and Robert F. Reilly

    Article first published online : 23 JAN 2008, DOI: 10.1111/j.1525-139X.2007.00408.x

  2. Nephrogenic systemic fibrosis and the role of gadolinium contrast media

    Journal of Medical Imaging and Radiation Oncology

    Volume 52, Issue 4, August 2008, Pages: 339–350, AJ Van Der Molen

    Article first published online : 16 SEP 2008, DOI: 10.1111/j.1440-1673.2008.01965.x

  3. Risk factors for NSF: A literature review

    Journal of Magnetic Resonance Imaging

    Volume 30, Issue 6, December 2009, Pages: 1298–1308, Martin R. Prince, Hong Lei Zhang, Giles H. Roditi, Tim Leiner and Walter Kucharczyk

    Article first published online : 24 NOV 2009, DOI: 10.1002/jmri.21973

  4. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case–control study from Denmark

    British Journal of Dermatology

    Volume 165, Issue 4, October 2011, Pages: 828–836, T.R. Elmholdt, M. Pedersen, B. Jørgensen, K. Søndergaard, J.D. Jensen, M. Ramsing and A.B. Olesen

    Article first published online : 27 SEP 2011, DOI: 10.1111/j.1365-2133.2011.10465.x

  5. NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis: Recommendations for Gadolinium-Based Contrast Use in Patients with Kidney Disease

    Seminars in Dialysis

    Volume 21, Issue 2, March/April 2008, Pages: 171–173, Mark A. Perazella and Robert F. Reilly

    Article first published online : 23 JAN 2008, DOI: 10.1111/j.1525-139X.2007.00402.x

  6. Nephrogenic systemic fibrosis: Clinical spectrum of disease

    Journal of Magnetic Resonance Imaging

    Volume 30, Issue 6, December 2009, Pages: 1289–1297, Michael Mayr, Felix Burkhalter and Georg Bongartz

    Article first published online : 24 NOV 2009, DOI: 10.1002/jmri.21975

  7. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents

    Journal of Magnetic Resonance Imaging

    Emmanuil Smorodinsky, David S. Ansdell, Zeke W. Foster, Sameer M. Mazhar, Irene Cruite, Tanya Wolfson, Sebastian B. Sugay, Gabriella Iussich, Masoud Shiehmorteza, Yuko Kono, Alexander Kuo and Claude B. Sirlin

    Article first published online : 9 MAY 2014, DOI: 10.1002/jmri.24650

  8. You have free access to this content
    Validation of a Screening Instrument for Nephrogenic Systemic Fibrosis

    Arthritis Care & Research

    Volume 65, Issue 4, April 2013, Pages: 637–642, Xinaida Taligare Lima, Maria Beatrice Alora-Palli, Alexandra Boer Kimball and Jonathan Kay

    Article first published online : 28 MAR 2013, DOI: 10.1002/acr.21877

  9. You have free access to this content
    Gadolinium – is it to blame?

    Journal of Cutaneous Pathology

    Volume 35, Issue 5, May 2008, Pages: 520–522, Shawn E. Cowper

    Article first published online : 8 APR 2008, DOI: 10.1111/j.1600-0560.2008.01027.x

  10. MRI contrast agents: Basic chemistry and safety

    Journal of Magnetic Resonance Imaging

    Volume 36, Issue 5, November 2012, Pages: 1060–1071, Dapeng Hao, Tao Ai, Frank Goerner, Xuemei Hu, Val M. Runge and Michael Tweedle

    Article first published online : 22 OCT 2012, DOI: 10.1002/jmri.23725

  11. NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Tissue Deposition of Gadolinium and Development of NSF: A Convergence of Factors

    Seminars in Dialysis

    Volume 21, Issue 2, March/April 2008, Pages: 150–154, Mark A. Perazella

    Article first published online : 23 JAN 2008, DOI: 10.1111/j.1525-139X.2007.00403.x

  12. You have free access to this content
    Gadolinium and nephrogenic systemic fibrosis: Association or causation (Review Article)

    Nephrology

    Volume 13, Issue 3, April 2008, Pages: 235–241, JAGADEESH KURTKOTI, THOMAS SNOW and BALAJI HIREMAGALUR

    Article first published online : 23 JAN 2008, DOI: 10.1111/j.1440-1797.2007.00912.x

  13. Gadolinium-Induced Nephrogenic Systemic Fibrosis Is Associated with Insoluble Gd Deposits in Tissues: In Vivo Transmetallation Confirmed by Microanalysis

    Journal of Cutaneous Pathology

    Volume 36, Issue 12, December 2009, Pages: 1244–1254, Charu Thakral and Jerrold L. Abraham

    Article first published online : 7 JUL 2009, DOI: 10.1111/j.1600-0560.2009.01283.x

  14. Gadolinium and Nephrogenic Systemic Fibrosis: Have We Overreacted?

    Seminars in Dialysis

    Volume 24, Issue 5, September/October 2011, Pages: 480–486, Jeffrey G. Penfield and Robert F. Reilly

    Article first published online : 13 SEP 2011, DOI: 10.1111/j.1525-139X.2011.00945.x

  15. Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients

    Journal of Magnetic Resonance Imaging

    Volume 30, Issue 6, December 2009, Pages: 1350–1356, Diego R. Martin, Richard C. Semelka, Arlene Chapman, Harm Peters, Paul J. Finn, Bobby Kalb and Henrik Thomsen

    Article first published online : 24 NOV 2009, DOI: 10.1002/jmri.21968

  16. “Carcinoid-Like” Tricuspid Valvulopathy Associated with Nephrogenic Systemic Fibrosis

    Echocardiography

    Volume 28, Issue 3, March 2011, Pages: E46–E49, S. Michael Gharacholou, Joseph J. Maleszewski, Barry A. Borlaug, Fernando G. Cosio, Joseph A. Dearani, Sudhir S. Kushwaha and Naser M. Ammash

    Article first published online : 3 MAR 2011, DOI: 10.1111/j.1540-8175.2010.01320.x

  17. Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: The role of excess ligand

    Journal of Magnetic Resonance Imaging

    Volume 27, Issue 5, May 2008, Pages: 955–962, Martin A. Sieber, Philipp Lengsfeld, Jakob Walter, Heiko Schirmer, Thomas Frenzel, Fred Siegmund, Hanns-Joachim Weinmann and Hubertus Pietsch

    Article first published online : 18 APR 2008, DOI: 10.1002/jmri.21368

  18. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure

    Journal of Cutaneous Pathology

    Volume 40, Issue 11, November 2013, Pages: 935–944, Susanne G. Schäd, Peter Heitland, W. Nikolaus Kühn-Velten, Gerd E. Gross and Ludwig Jonas

    Article first published online : 16 SEP 2013, DOI: 10.1111/cup.12214

  19. Update on nephrogenic systemic fibrosis: are we making progress?

    International Journal of Dermatology

    Volume 50, Issue 6, June 2011, Pages: 659–666, Anna K. Haemel, Elizabeth A. Sadowski, Martin M. Shafer and Arjang Djamali

    Article first published online : 20 MAY 2011, DOI: 10.1111/j.1365-4632.2010.04851.x

  20. The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange

    Journal of Clinical Apheresis

    Volume 28, Issue 4, August 2013, Pages: 317–320, Jessica L. Poisson, Aaron Low and Yara A. Park

    Article first published online : 21 FEB 2013, DOI: 10.1002/jca.21253